264 related articles for article (PubMed ID: 12592084)
1. Treatment of psoriatic nails with topical cyclosporin: a prospective, randomized placebo-controlled study.
Cannavò SP; Guarneri F; Vaccaro M; Borgia F; Guarneri B
Dermatology; 2003; 206(2):153-6. PubMed ID: 12592084
[TBL] [Abstract][Full Text] [Related]
2. Nail psoriasis: combined therapy with systemic cyclosporin and topical calcipotriol.
Feliciani C; Zampetti A; Forleo P; Cerritelli L; Amerio P; Proietto G; Tulli A; Amerio P
J Cutan Med Surg; 2004; 8(2):122-5. PubMed ID: 15129317
[TBL] [Abstract][Full Text] [Related]
3. Topical cyclosporine hydrogel preparation: A new therapeutic option in the treatment of nail psoriasis.
Gallo G; Mastorino L; Barilà D; Cattel F; Panzone M; Quaglino P; Ribero S; Dapavo P
Dermatol Ther; 2022 Dec; 35(12):e15917. PubMed ID: 36214268
[TBL] [Abstract][Full Text] [Related]
4. Effectiveness of systemic treatment agents on psoriatic nails: a comparative study.
Demirsoy EO; Kıran R; Salman S; Cağlayan C; Aktürk AS; Bayramgurler D; Bilen N
J Drugs Dermatol; 2013 Sep; 12(9):1039-43. PubMed ID: 24002153
[TBL] [Abstract][Full Text] [Related]
5. Recommendations for the definition, evaluation, and treatment of nail psoriasis in adult patients with no or mild skin psoriasis: A dermatologist and nail expert group consensus.
Rigopoulos D; Baran R; Chiheb S; Daniel CR; Di Chiacchio N; Gregoriou S; Grover C; Haneke E; Iorizzo M; Pasch M; Piraccini BM; Rich P; Richert B; Rompoti N; Rubin AI; Singal A; Starace M; Tosti A; Triantafyllopoulou I; Zaiac M
J Am Acad Dermatol; 2019 Jul; 81(1):228-240. PubMed ID: 30731172
[TBL] [Abstract][Full Text] [Related]
6. Topical calcipotriol therapy in nail psoriasis: a study of 24 cases.
Zakeri M; Valikhani M; Mortazavi H; Barzegari M
Dermatol Online J; 2005 Dec; 11(3):5. PubMed ID: 16409901
[TBL] [Abstract][Full Text] [Related]
7. Ixekizumab Is Effective in Subjects With Moderate to Severe Plaque Psoriasis With Significant Nail Involvement: Results From UNCOVER 3.
Dennehy EB; Zhang L; Amato D; Goldblum O; Rich P
J Drugs Dermatol; 2016 Aug; 15(8):958-61. PubMed ID: 27537996
[TBL] [Abstract][Full Text] [Related]
8. Tacrolimus 0.1% ointment in nail psoriasis: a randomized controlled open-label study.
De Simone C; Maiorino A; Tassone F; D'Agostino M; Caldarola G
J Eur Acad Dermatol Venereol; 2013 Aug; 27(8):1003-6. PubMed ID: 22788697
[TBL] [Abstract][Full Text] [Related]
9. Intramatricial injections for nail psoriasis: An open-label comparative study of triamcinolone, methotrexate, and cyclosporine.
Mittal J; Mahajan BB
Indian J Dermatol Venereol Leprol; 2018; 84(4):419-423. PubMed ID: 29536977
[TBL] [Abstract][Full Text] [Related]
10. Instability of topical ciclosporin emulsion for nail psoriasis.
Prins AM; Vos K; Franssen EJ
Dermatology; 2007; 215(4):362-3. PubMed ID: 17911999
[No Abstract] [Full Text] [Related]
11. Ustekinumab improves nail disease in patients with moderate-to-severe psoriasis: results from PHOENIX 1.
Rich P; Bourcier M; Sofen H; Fakharzadeh S; Wasfi Y; Wang Y; Kerkmann U; Ghislain PD; Poulin Y;
Br J Dermatol; 2014 Feb; 170(2):398-407. PubMed ID: 24117389
[TBL] [Abstract][Full Text] [Related]
12. Topical cyclosporine versus emulsion vehicle for the treatment of brittle nails: a randomized controlled pilot study.
Mackay-Wiggan J; Marji J; Walt JG; Campbell A; Coppola C; Chakraborty B; Hollander DA; Whitcup SM
J Drugs Dermatol; 2014 Oct; 13(10):1232-9. PubMed ID: 25607558
[TBL] [Abstract][Full Text] [Related]
13. Evaluation of the efficacy and safety of infliximab on psoriatic nails: an unblinded, nonrandomized, open-label study.
Rigopoulos D; Gregoriou S; Stratigos A; Larios G; Korfitis C; Papaioannou D; Antoniou C; Ioannides D
Br J Dermatol; 2008 Aug; 159(2):453-6. PubMed ID: 18565184
[TBL] [Abstract][Full Text] [Related]
14. Efficacy of pulsed dye laser plus topical tazarotene versus topical tazarotene alone in psoriatic nail disease: a single-blind, intrapatient left-to-right controlled study.
Huang YC; Chou CL; Chiang YY
Lasers Surg Med; 2013 Feb; 45(2):102-7. PubMed ID: 23423871
[TBL] [Abstract][Full Text] [Related]
15. Nail psoriasis: a retrospective study on the effectiveness of systemic treatments (classical and biological therapy).
Sánchez-Regaña M; Sola-Ortigosa J; Alsina-Gibert M; Vidal-Fernández M; Umbert-Millet P
J Eur Acad Dermatol Venereol; 2011 May; 25(5):579-86. PubMed ID: 21198950
[TBL] [Abstract][Full Text] [Related]
16. A 24-week randomized clinical trial investigating the efficacy and safety of two doses of etanercept in nail psoriasis.
Ortonne JP; Paul C; Berardesca E; Marino V; Gallo G; Brault Y; Germain JM
Br J Dermatol; 2013 May; 168(5):1080-7. PubMed ID: 23013207
[TBL] [Abstract][Full Text] [Related]
17. Improvement of quality of life and clinical usefulness of cyclosporin administration in patients with nail psoriasis.
Abe M; Syuto T; Yokoyama Y; Ishikawa O
J Dermatol; 2011 Sep; 38(9):916-8. PubMed ID: 21352333
[No Abstract] [Full Text] [Related]
18. Evaluation of the efficacy of methotrexate and cyclosporine therapies on psoriatic nails: a one-blind, randomized study.
Gümüşel M; Özdemir M; Mevlitoğlu I; Bodur S
J Eur Acad Dermatol Venereol; 2011 Sep; 25(9):1080-4. PubMed ID: 21118309
[TBL] [Abstract][Full Text] [Related]
19. Nail psoriasis: treatment with tazarotene 0.1% hydrophilic ointment.
Fischer-Levancini C; Sánchez-Regaña M; Llambí F; Collgros H; Expósito-Serrano V; Umbert-Millet P
Actas Dermosifiliogr; 2012 Oct; 103(8):725-8. PubMed ID: 22818395
[TBL] [Abstract][Full Text] [Related]
20. Nail psoriasis improvement in a patient treated with fumaric acid esters.
Vlachou C; Berth-Jones J
J Dermatolog Treat; 2007; 18(3):175-7. PubMed ID: 17538807
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
